December 14, 2020, Moscow - The Association of International Pharmaceutical Manufacturers (AIPM) announces an addition to its membership. Pursuant to a resolution of the General Meeting, the STADA pharmaceutical company has been admitted to AIPM.
It reflects the extreme concern of the professional community about the risk of interruptions in the supply of medicines to the population of the Russian Federation in connection with the expected introduction of the Trace & Track system for medicines as of July 01, 2020.
April 9, 2020, Moscow – The international pharmaceutical industry reaffirms its global and regional commitment to attract the industry expertise and know-how needed to accelerate the development of safe and effective new vaccines, diagnostics and treatments to use in the fight against COVID-19 in collaboration with all stakeholders. In context of the COVID-19 pandemic and unprecedented challenges for public healthcare, companies and leading global industry associations – IFPMA (International Federation of Pharmaceutical Manufacturers & Association) and EFPIA (European Federation of Pharmaceutical Industries and Associations), of which AIPM is a member – have voiced their willingness to support public healthcare systems around the world during these difficult times.
February 26, 2020, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces that Board of Directors has confirmed the authority of Vasily Ignatiev, CEO of R-Pharm, as Vice Chairman of the AIPM Board of Directors for the second term.
3 February 2020, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces that according to the Statutes and by the decision of the AIPM Board of Directors Mrs. Oxana Monge, General Manager, Sanofi Eurasia, has been elected the Chair of the Board of Directors at AIPM.
Introduction of the Track&Trace system for medicines has been discussed at Izvestiya Multimedia Information Center (MIC).
Representatives of the EEC and regulatory authorities of EAEU member-states, industry associations and the sector in cooperation with the leading international experts discussed the prospects, key challenges and law enforcement issues in creation of the common market of medicines in the EAEU and EU.
Representatives of the Association of International Pharmaceutical Manufacturers talk about their contribution to achieving key national health indicators: #aipm25to80, #pharma_onthewayto80, #вместеради80плюс, #aipm25
On June 18, 2018 in Moscow the Regulatory Workshop was organized by Eurasian Economic Commission and AIPM & EFPIA with participation (F2F & VC format) of regulatory authorities of EAEU member-states, EU regulators, IT specialists and industry to discuss regulatory aspects, practical implementation issues and road map of eCTD implementation in ICH region & electronic submissions in EAEU region.
On May 15, 2018 in the frame of Russian Pharmaceutical Forum in St. Petersburg, a press briefing of the Association of International Pharmaceutical Manufacturers (AIPM) was held, entitled “PHARMA 2030: what is needed to develop innovation and attract investment in the pharmaceutical industry in Russia?”.
At the end of April, 2018 the EAEU common market, regulating the circulation of medicines in the Union, was officially presented in Brussels within the framework of the international conference “Regional pharmaceutical markets of the European Union and the Eurasian Economic Union – trends, challenges and best regulatory practices”.
February 21, 2018, Moscow – The Association of International Pharmaceutical Manufactures (AIPM) announces that according to the Statutes and by the decision of the AIPM Board of Director, Vasily Ignatiev, CEO, R-Pharm, has been elected Vice Chairman of the AIPM Board of Directors.
On April 7, 2017 – Association of international pharmaceutical manufacturers (AIPM) announces the expansion of its membership. AIPM General Assembly held on April 6, 2017 unanimously decided to include the international pharmaceutical company CSL Behring in the AIPM.